Page last updated: 2024-11-12

duocarmycin b1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

duocarmycin B1: from Streptomyces sp. DO-89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15100413
CHEMBL ID322666
SCHEMBL ID19493153
MeSH IDM0168422

Synonyms (11)

Synonym
duocarmycin b1
CHEMBL322666
124325-93-5
1h-pyrrolo(3,2-f)quinoline-2-carboxylic acid, 8-bromo-2,3,6,7,8,9-hexahydro-4-hydroxy-2-methyl-1-oxo-6-((5,6,7-trimethoxy-1h-indol-2-yl)carbonyl)-, methyl ester, (2r-trans)-
niosh/jv1200000
JV12000000
duocarmycin b(sub 1)
SCHEMBL19493153
DTXSID50924782
methyl (2r,8s)-8-bromo-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3,7,8,9-tetrahydropyrrolo[3,2-f]quinoline-2-carboxylate
1h-pyrrolo3,2-fquinoline-2-carboxylic acid, 8-bromo-2,3,6,7,8,9-hexahydro-4-hydroxy-2-methyl-1-oxo-6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID87752In vitro anticellular activity against HeLa S3 cells 72 hr after administration of the compound1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
Synthesis and antitumor activity of water-soluble duocarmycin B1 prodrugs.
AID201731In vivo antitumor activity against Sarcoma 180 at dose 0.5 mg/kg1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
Synthesis and antitumor activity of water-soluble duocarmycin B1 prodrugs.
AID87751In vitro anticellular activity against HeLa S3 cells 1 hr after administration of the compound1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
Synthesis and antitumor activity of water-soluble duocarmycin B1 prodrugs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's5 (55.56)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (22.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]